SCHEMBL18824633

SCHEMBL18824633

Fc1cccc(Br)c1C1=NCCCN1

nearest known ligand 0.49

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ NISCH Q9Y2I1 10/20 0.49
▸ GAA P10253 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ TOP2A P11388 4/20 0.41
▸ TOP2B Q02880 4/20 0.41
▸ MC4R P32245 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13830897 0.88 NISCH (0.56) NISCHGAATSHRTOP2ATOP2B
SCHEMBL18824741 0.81 NISCH (0.50) NISCHGAATSHRTOP2ATOP2B
SCHEMBL18824746 0.75 NISCH (0.60) NISCHGAATSHRTOP2ATOP2B
SCHEMBL13830922 0.75 NISCH (0.58) NISCHGAATSHRTOP2ATOP2B
SCHEMBL13831444 0.70 NISCH (0.77) NISCHGAATSHRTOP2ATOP2B
SCHEMBL13830691 0.70 NISCH (0.55) NISCHGAATSHRTOP2ATOP2B
SCHEMBL18824711 0.70 NISCH (0.55) NISCHGAATSHRTOP2ATOP2B
SCHEMBL13830762 0.70 NISCH (0.49) NISCHGAATSHRTOP2ATOP2B
SCHEMBL13831194 0.70 NISCH (0.55) NISCHGAATSHRTOP2ATOP2B
SCHEMBL14029044 0.68 NISCH (0.75) NISCHGAATSHRTOP2ATOP2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11801251-B2 Selective HDAC8 inhibitors and their uses HOCHSCHULE DARMSTADT (DE) 2023-10-31 — — US disclosed
US-20210220370-A1 SELECTIVE HDAC8 INHIBITORS AND THEIR USES HOCHSCHULE DARMSTADT (DE) 2021-07-22 — — US disclosed
EP-3371195-B1 SELECTIVE HDAC8 INHIBITORS AND THEIR USES HOCHSCHULE DARMSTADT (DE) 2021-04-21 — — EP disclosed
US-20180311257-A1 SELECTIVE HDAC8 INHIBITORS AND THEIR USES HOCHSCHULE DARMSTADT (DE) 2018-11-01 — — US disclosed
EP-3371195-A1 SELECTIVE HDAC8 INHIBITORS AND THEIR USES Hochschule Darmstadt (DE) 2018-09-12 — — EP disclosed
WO-2017077008-A1 SELECTIVE HDAC8 INHIBITORS AND THEIR USES HOCHSCHULE DARMSTADT (DE) 2017-05-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180311257-A1 SELECTIVE HDAC8 INHIBITORS AND THEIR USES HDAC8, HDAC5, HDAC7 NISCH 3504/4885GAA 278/4885TSHR 3718/4885
US-11801251-B2 Selective HDAC8 inhibitors and their uses HDAC8, HDAC5, HDAC7 NISCH 3504/4885GAA 278/4885TSHR 3718/4885
US-20210220370-A1 SELECTIVE HDAC8 INHIBITORS AND THEIR USES HDAC8, HDAC5, HDAC7 NISCH 3504/4885GAA 278/4885TSHR 3718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback